Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Peptide 144 TGF- β1 inhibitor (TSLDASIIWAMMQN)

EU orphan designation number: EU/3/05/326   
Active ingredient: Peptide 144 TGF- β1 inhibitor (TSLDASIIWAMMQN)
Indication: Treatment of systemic sclerosis
Sponsor: Digna Biotech S.L.
Avenida Pio XII, 22, oficina 2, E-31008 Pamplona, Navarra, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/11/2005 Orphan designation EMEA/OD/035/05 (2005)4354 of 28/10/2005
22/06/2010 Change of name and/or address of sponsor EMEA/OD/035/05